Sana Biotechnology SANA Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $83.8M-12.8% | $71.87M-43.7% | $103.36M-18.6% | $71.27M-47.2% | $96.13M-45.7% | ||
| $17.34M+102% | $66.51M+167% | $49.7M-31.0% | $1.4M-98.8% | $8.57M-93.6% | ||
| $4.2M0.0% | $4.2M+9.5% | $4.2M+9.5% | $4.2M+9.5% | $4.2M+9.5% | ||
| $22.6M-4.2% | $20.08M-23.1% | $18.46M-29.4% | $21.26M-18.0% | $23.6M-3.9% | ||
| $111.69M-0.9% | $148.68M-7.5% | $161.76M-23.0% | $82.5M-68.7% | $112.73M-64.9% | ||
| $25.67M-65.2% | $26.91M-65.2% | $29.93M-63.9% | $33.08M-61.5% | $73.69M-9.8% | ||
| $35.85M-34.6% | $38.31M-33.9% | $40.7M-33.3% | $43.02M-31.9% | $54.84M-23.4% | ||
| $140.63M0.0% | $140.63M0.0% | $140.63M0.0% | $140.63M0.0% | $140.63M0.0% | ||
| $59.2M0.0% | $59.2M0.0% | $59.2M0.0% | $59.2M0.0% | $59.2M0.0% | ||
| $563K-87.2% | $3.17M-38.0% | $3.22M-42.1% | $3.22M-49.1% | $4.39M-37.9% | ||
| $373.59M-16.1% | $416.89M-16.8% | $435.43M-22.2% | $361.65M-41.5% | $445.47M-34.6% | ||
| $7.92M-39.1% | $6.79M-62.5% | $10.33M-39.3% | $11.46M-52.1% | $13.01M-44.0% | ||
| $7.58M-18.9% | $13.24M-8.4% | $11.3M-37.4% | $9.41M-39.6% | $9.35M-33.0% | ||
| $14.88M+14.4% | $14.94M+19.2% | $14.37M+35.5% | $13.83M+38.3% | $13M-1.2% | ||
| $86.27M+160% | $78.73M+73.3% | $35.51M-24.4% | $33.44M-34.0% | $33.16M-37.3% | ||
| $60.45M-22.8% | $63.92M-21.7% | $67.87M-20.6% | $71.66M-19.1% | $78.31M-15.7% | ||
| $75.33M-17.5% | $78.86M-16.3% | $82.24M-14.4% | $85.49M-13.3% | $91.31M-13.9% | ||
| $9.81M+3.8% | $10.6M— | $7.88M— | $8.24M— | $9.44M— | ||
| $254.35M+7.6% | $256.01M+2.2% | $240.12M-10.0% | $239.09M-14.3% | $236.39M-22.8% | ||
| $27K+17.4% | $27K+22.7% | $26K+18.2% | $23K+4.5% | $23K+4.5% | ||
| $2.02B+8.2% | $2.01B+8.3% | $1.99B+7.4% | $1.87B+1.9% | $1.86B+2.3% | ||
| -$1.9B-14.6% | -$1.85B-15.2% | -$1.79B-15.1% | -$1.75B-16.9% | -$1.65B-14.4% | ||
| -$2K— | $28K+100% | $21K-61.1% | $0+100% | $0+100% | ||
| $119.24M-43.0% | $160.88M-35.8% | $195.31M-33.2% | $122.56M-63.9% | $209.08M-44.3% | ||
| $373.59M-16.1% | $416.89M-16.8% | $435.43M-22.2% | $361.65M-41.5% | $445.47M-34.6% | ||
| $17.34M+102% | $66.51M+167% | $49.7M-31.0% | $1.4M-98.8% | $8.57M-93.6% | ||
| $563K-87.2% | $3.17M-38.0% | $3.22M-42.1% | $3.22M-49.1% | $4.39M-37.9% | ||
| $35.85M-34.6% | $38.31M-33.9% | $40.7M-33.3% | $43.02M-31.9% | $54.84M-23.4% | ||
| $59.2M0.0% | $59.2M0.0% | $59.2M0.0% | $59.2M0.0% | $59.2M0.0% | ||
| $35.85M-34.6% | $38.31M-33.9% | $40.7M-33.3% | $43.02M-31.9% | $54.84M-23.4% | ||
| $563K-87.2% | $3.17M-38.0% | $3.22M-42.1% | $3.22M-49.1% | $4.39M-37.9% | ||
| $35.85M-34.6% | $38.31M-33.9% | $40.7M-33.3% | $43.02M-31.9% | $54.84M-23.4% | ||
| $563K-87.2% | $3.17M-38.0% | $3.22M-42.1% | $3.22M-49.1% | $4.39M-37.9% | ||
| $7.58M-18.9% | $13.24M-8.4% | $11.3M-37.4% | $9.41M-39.6% | $9.35M-33.0% | ||
| $7.58M-18.9% | $13.24M-8.4% | $11.3M-37.4% | $9.41M-39.6% | $9.35M-33.0% | ||
| $80.91M-27.0% | $83.52M-23.4% | $115.14M+2.9% | $117.13M+4.9% | $110.83M-3.6% | ||
| $8.12M-17.2% | $8.68M-34.4% | $7.99M-48.0% | $7.93M-62.8% | $9.81M-50.1% | ||
| $75.33M-17.5% | $78.86M-16.3% | $82.24M-14.4% | $85.49M-13.3% | $91.31M-13.9% | ||
| $27K+17.4% | $27K+22.7% | $26K+18.2% | $23K+4.5% | $23K+4.5% | ||
| $16.93M+264% | $19.24M+322% | $13.73M-9.2% | $8.61M-58.7% | $4.65M-89.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Sana Biotechnology's total assets?
- Sana Biotechnology (SANA) holds $373.6M in total assets, down 16.1% year over year.
- How much debt does Sana Biotechnology have?
- Sana Biotechnology carries $75.3M in total debt against $119.2M of shareholders' equity, a debt-to-equity ratio of 0.63.
- How much cash does Sana Biotechnology have?
- Sana Biotechnology holds $83.8M in cash and equivalents.
- Can Sana Biotechnology cover its short-term obligations?
- Its current ratio is 1.29 — current assets exceed current liabilities.
- Where does Sana Biotechnology's balance sheet data come from?
- Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.